Structure–activity relationship analysis of a novel necroptosis inhibitor, Necrostatin-5
Authors:
- Jinfeng LiJLJinfeng Li
- Alexei DegterevADAlexei Degterev
- Emily HsuEHEmily Hsu
- Junying YuanJYJunying Yuan
- Chengye YuanCYChengye Yuan
- 1 March 2007
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 17 (5) , 1455-1465
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Structure–activity relationship study of novel necroptosis inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injuryNature Chemical Biology, 2005
- A decade of caspasesOncogene, 2003
- Diversity in the Mechanisms of Neuronal Cell DeathNeuron, 2003
- Necrotic Death Pathway in FAS Receptor SignalingJournal of Cell Biology, 2000
- Fas triggers an alternative, caspase-8–independent cell death pathway using the kinase RIP as effector moleculeNature Immunology, 2000
- Fas (CD95/APO-1) plays a role in the pathophysiology of focal cerebral ischemiaJournal of Neuroscience Research, 2000
- Caspase-independent Cell Killing by Fas-associated Protein with Death DomainJournal of Cell Biology, 1998
- Dual Signaling of the Fas Receptor: Initiation of Both Apoptotic and Necrotic Cell Death PathwaysJournal of Experimental Medicine, 1998
- Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitroNeuroscience, 1995